Omni Bio Pharmaceutical Inc OMBP:OTCBB - OTC Pink Current Information (Common Stock)
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
|---|---|---|---|---|
| 0.19 | -0.02 -9.52% | 35,486 | 6.8K |
Latest News Headlines for Omni Bio Pharmaceutical Inc
Latest Annual and Quarterly SEC Filings
More FilingsCompany Background
Omni Bio Pharmaceutical, Inc. (Omni Bio) is a development-stage company. The Company is a biopharmaceutical company that was initially formed to explore new methods of use of Alpha-1 antitrypsin (AAT), also referred to as plasma-derived AAT. The Company holds a license to an issued method of use patent for the treatment of diabetes using p-AAT with a privately-held company, Bio Holding, Inc. In addition, it holds licenses with the Regents of the University of Colorado (RUC) for method of use patents and patent applications (Use Patents) covering the use of p-AAT in the indications: cellular transplantation and graft rejection, radiation protection, certain bacterial and viral diseases, myocardial remodeling and inflammatory bowel disease. It also hold licenses with RUC for patent applications covering composition of matter for various Fc-AAT constructs.
collapse, right-facing arrow indicating collapsed view of sectionOverview
| Bid | Size | -- | -- |
|---|---|
| Ask | Size | -- | -- |
| Price Open | 0.19 |
| Previous Close | 0.19 |
| Day High | -- |
| Day Low | -- |
| 52 Week High | 1/24/2014 | 0.50 |
| 52 Week Low | 10/11/2013 | 0.1201 |
| % Off 52 Week High | -62.00% |
| % Off 52 Week Low | 58.20% |
| Beta (5 Yr) | -0.23 |
| Volatility Avg | 10/8/2014 | 210.18 |
| 10-Day Avg. Volume | 6,763 |
| Market data is delayed by at least 20 minutes. | |
collapse, right-facing arrow indicating collapsed view of sectionFundamentals
| EPS (TTM) | 6/30/2014 | -0.07 |
|---|---|
| P/E Ratio | 6/30/2014 | -- |
| Market Cap | Micro Cap | 7M |
| Shares Outstanding | 38.86M |
| Float | 23.5M |
collapse, right-facing arrow indicating collapsed view of sectionDividends
| Dividend Yield | -- |
|---|---|
| Ex-Date | -- |
| Dividend Announcement | -- |
| Date of Record | -- |
| Payable | -- - -- |
| Payable Date | -- |
Peers Information HelpOMBP Omni Bio Pharmaceutical Inc vs. Peers
| Peers | |
|---|---|
OMBP Omni Bio Pharmaceutical Inc | -50.48% |
Johnson & Johnson | 14.54% |
Merck & Co., Inc. | 20.24% |
Amgen, Inc. | 22.78% |
Gilead Sciences, Inc. | 44.97% |
OMBP Omni Bio Pharmaceutical Inc | 0.00% |
Johnson & Johnson | 2.67% |
Merck & Co., Inc. | 2.92% |
Amgen, Inc. | 1.74% |
Gilead Sciences, Inc. | -- |
OMBP Omni Bio Pharmaceutical Inc | -9.52% |
Johnson & Johnson | 2.46% |
Merck & Co., Inc. | 2.94% |
Amgen, Inc. | 2.97% |
Gilead Sciences, Inc. | -100.00% |